Condition

Chronic Inflammation

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19
Recruiting3
Common interventions22
Lead sponsors shown15
Advertisement

Clinical trials

19 shown
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade InflammationNCT07247734 · 2025-12-01
RECRUITING
Pilot Study of the Human Metagenome in Metabolic DiseasesNCT06363253 · 2023-08-14
RECRUITING
Investigating the Link Between Type 2 Immunity and NAFLD in Human ObesityNCT04232566 · 2022-02-20
RECRUITING
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIVNCT06935838 · 2025-11-12
COMPLETED
Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and InflammationNCT06604611 · 2024-10-31
UNKNOWN
Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine LevelsNCT06622304 · 2024-04-01
COMPLETED
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 DiabetesNCT05949281 · 2023-08-29
ACTIVE_NOT_RECRUITING
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIVNCT05209867 · 2022-05-01
COMPLETED
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)NCT04979130 · 2022-01-01
COMPLETED
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish)NCT05068557 · 2021-09-24
UNKNOWN
The Grounded Brain: How Sleeping Grounded Affects Memory and PerceptionsNCT05050812 · 2021-09-01
UNKNOWN
The BMI Project (Body, Mind, Inflammation)NCT04023318 · 2019-07-15
COMPLETED
Systematic Review and Meta-analysis of the Differential Effects of DHA and EPA on InflammationNCT03520556 · 2018-04-16
COMPLETED
30-to-90 Day Challenge: Effects of Alcohol Cessation on Health OutcomesNCT03353701 · 2017-12-11
COMPLETED
Impact of Gut Hormones and Inflammatory Adipokines in Obese Patients Underwent Bariatric SurgeryNCT02963662 · 2015-10-01
COMPLETED
PatientSpot Formerly Known as ArthritisPowerNCT03840928 · 2015-04-01
UNKNOWN
The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric BypassNCT07241741 · 2015-01-01
COMPLETED
Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy YogurtNCT01686204 · 2012-09-01
COMPLETED
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).NCT00211471 · 2002-03-01
TERMINATED

Common interventions

Trial status mix

COMPLETED10
UNKNOWN4
RECRUITING3
ACTIVE_NOT_RECRUITING1
TERMINATED1

Phase mix

NA6
PHASE24
PHASE43
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.